Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Kelly

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Clinical Colorectal Cancer|March 26, 2023
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS)Mark P Saunders, Rohan Iype, Caroline Kelly, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysisPauline Corbaux, Benoit You, Tatsuo Kagimura, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2023
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysisPauline Corbaux, Benoit You, Rosalind M Glasspool, et al.
Cell Reports. Medicine|September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancerMarta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 3, 2022
Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II studyPhilip J Asherson, Lena Johansson, Rachel Holland, et al.
Gynecologic Oncology|August 20, 2021
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trialSusana N Banerjee, Monica Tang, Rachel L O'Connell, et al.
British Journal of Cancer|November 23, 2020
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant TrialsClaire Gallois, Qian Shi, Jeffrey P Meyers, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trialMatthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Clinical Colorectal Cancer|March 26, 2023
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS)Mark P Saunders, Rohan Iype, Caroline Kelly, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysisPauline Corbaux, Benoit You, Tatsuo Kagimura, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2023
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysisPauline Corbaux, Benoit You, Rosalind M Glasspool, et al.
Cell Reports. Medicine|September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancerMarta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 3, 2022
Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II studyPhilip J Asherson, Lena Johansson, Rachel Holland, et al.
Gynecologic Oncology|August 20, 2021
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trialSusana N Banerjee, Monica Tang, Rachel L O'Connell, et al.
British Journal of Cancer|November 23, 2020
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancerPeter G Alexander, Antonia K Roseweir, Kathryn A F Pennel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG StudiesEnric Domingo, Caroline Kelly, Jennifer Hay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant TrialsClaire Gallois, Qian Shi, Jeffrey P Meyers, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trialMatthew Tate, Christopher J R Illingworth, Gordon MacGregor, et al.
Pageof 5